Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-022064

President, SaaS Business sold 10,000 shares at $216.60 ($2,166,000)

  • President, SaaS Business acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ghoshal Kaushik · President, SaaS Business

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-12 Exercise or conversion : show line 1 in the form 10b5-1 +2,086 $95.80 $199,839 15,118 D
2024-08-12 Exercise or conversion : show line 2 in the form 10b5-1 +6,877 $95.80 $658,817 21,995 D
2024-08-12 Exercise or conversion : show line 3 in the form 10b5-1 +1,037 $101.64 $105,401 23,032 D
2024-08-12 Sale : show line 4 in the form 10b5-1 −10,000 $216.60 $2,166,000 13,032 D
Open-market sales · 10,000 sh · avg $216.60 · $2,166,000

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-08-12 Exercise or conversion : show line 5 in the form 10b5-1 ResMed Common Stock Options −2,086 0 D
2024-08-12 Exercise or conversion : show line 6 in the form 10b5-1 ResMed Common Stock Options −6,877 0 D
2024-08-12 Exercise or conversion : show line 7 in the form 10b5-1 ResMed Common Stock Options −1,037 9,260 D
Loading xslF345X05/form4.xml…